As psy­che­del­ic drugs inch clos­er to com­mer­cial­iza­tion, two House law­mak­ers are chart­ing a path for­ward for their in­evitable roll­out and what any po­ten­tial ac­com­pa­ny­ing leg­is­la­tion...

MI­LAN— Re­gen­eron’s in­ves­ti­ga­tion­al drug helped obe­si­ty pa­tients who stopped tak­ing No­vo’s We­govy re­gain a sim­i­lar amount of mus­cle mass to what they lost when...

Plus news about No­vo, Nek­tar, Min­dRank, Mab­well Bio­science, Atara Bio­ther­a­peu­tics, Pierre Fab­re, Monte Rosa and Sko­pos Bio.

Unit­ed Ther­a­peu­tics wins court bat­tle: A fed­er­al court...

Last week, An­throp­ic said its AI sys­tem made its first sci­en­tif­ic dis­cov­ery.

Claude agents had dis­cov­ered a new en­zyme sys­tem, the AI gi­ant said, pub­li­ciz­ing the find­ings...

Eli Lil­ly is walk­ing away from Foghorn Ther­a­peu­tic­s' "syn­thet­ic lethal­i­ty" drug de­vel­op­ment, and the small biotech is re­duc­ing its head­count by 40% as a re­sult...